Bastian Grothey

Kerpener Str. 62
Koeln, NW 50937, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Immune cell clustering identifies a CD163⁺/CSF1R⁺ macrophage and neutrophil-enriched phenotype with distinct biological signatures and poor prognosis in angiosarcoma.

Immune cell clustering identifies a CD163⁺/CSF1R⁺ macrophage and neutrophil-enriched phenotype with distinct biological signatures and poor prognosis in angiosarcoma.

Journal: Oncoimmunology

Published: March 23, 2026

SMARCA2 and SMARCA4-deficiency is associated with a distinct molecular and microenvironmental subtype of esophageal adenocarcinoma.

SMARCA2 and SMARCA4-deficiency is associated with a distinct molecular and microenvironmental subtype of esophageal adenocarcinoma.

Journal: Scientific reports

Published: March 06, 2026

Sex-Specific Proteomic Profiling Identifies Pregnancy Zone Protein as a Complement-Linked Marker of Adverse Prognosis in Esophageal Adenocarcinoma.

Sex-Specific Proteomic Profiling Identifies Pregnancy Zone Protein as a Complement-Linked Marker of Adverse Prognosis in Esophageal Adenocarcinoma.

Journal: International journal of cancer

Published: February 12, 2026

Amplification cycles through innate lymphoid cells at the onset of lupus nephritis.

Amplification cycles through innate lymphoid cells at the onset of lupus nephritis.

Journal: Frontiers in immunology

Published: November 28, 2025

Proteomic characterization of SMARCA-deficient esophageal adenocarcinoma reveals complement evasion and DNA repair-associated prognostic subgroups.

Proteomic characterization of SMARCA-deficient esophageal adenocarcinoma reveals complement evasion and DNA repair-associated prognostic subgroups.

Journal: British journal of cancer

Published: November 26, 2025

Adherens junction protein expression is associated with poor response to neoadjuvant FLOT chemotherapy and pro-inflammatory tumor microenvironment in esophageal adenocarcinoma.

Adherens junction protein expression is associated with poor response to neoadjuvant FLOT chemotherapy and pro-inflammatory tumor microenvironment in esophageal adenocarcinoma.

Journal: International journal of cancer

Published: July 18, 2025

MDM2-amplified esophageal adenocarcinomas exhibit an activated metabolic and immunosuppressive phenotype with multiple potential therapeutic targets.

MDM2-amplified esophageal adenocarcinomas exhibit an activated metabolic and immunosuppressive phenotype with multiple potential therapeutic targets.

Journal: BMC cancer

Published: June 30, 2025

Basal-like subtype of esophageal adenocarcinoma and it's morphological, molecular and clinical characteristics.

Basal-like subtype of esophageal adenocarcinoma and it's morphological, molecular and clinical characteristics.

Journal: Scientific reports

Published: April 07, 2025

Proteomic characterization of MET-amplified esophageal adenocarcinomas reveals enrichment of alternative splicing- and androgen signaling-related proteins.

Proteomic characterization of MET-amplified esophageal adenocarcinomas reveals enrichment of alternative splicing- and androgen signaling-related proteins.

Journal: Cellular and molecular life sciences : CMLS

Published: September 10, 2024

Comprehensive testing of large language models for extraction of structured data in pathology.

Comprehensive testing of large language models for extraction of structured data in pathology.

Journal: Communications medicine

Published: June 09, 2024

Showing 1-10 of 10

Last Updated: 09/26/2026